PharmaCyte Biotech (PMCB) Receivables - Other (2013)

PharmaCyte Biotech (PMCB) has reported Receivables - Other for 1 consecutive years, with $2.3 million the latest figure, recorded in Q2 2013.

• In Q2 2013, Receivables - Other changed N/A year-over-year to $2.3 million; the TTM figure through Apr 2013 stood at $2.3 million (changed N/A YoY), while the FY2013 annual figure was $2.3 million, changed N/A from the prior year.
• Receivables - Other steadied at $2.3 million in Q2 2013 per PMCB's latest filing.
• Across five years, Receivables - Other topped out at $2.3 million in Q2 2013 and bottomed at $2.3 million in Q2 2013.